ANTRENYL Drug Patent Profile
✉ Email this page to a colleague
When do Antrenyl patents expire, and what generic alternatives are available?
Antrenyl is a drug marketed by Novartis and is included in one NDA.
The generic ingredient in ANTRENYL is oxyphenonium bromide. Additional details are available on the oxyphenonium bromide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ANTRENYL?
- What are the global sales for ANTRENYL?
- What is Average Wholesale Price for ANTRENYL?
Summary for ANTRENYL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 46 |
| Patent Applications: | 743 |
| DailyMed Link: | ANTRENYL at DailyMed |
US Patents and Regulatory Information for ANTRENYL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novartis | ANTRENYL | oxyphenonium bromide | TABLET;ORAL | 008492-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
